What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- T cell
Her scientific interests lie mostly in Cytotoxic T cell, Immunology, T cell, T-cell receptor and CD8.
As part of the same scientific family, Mirjam H.M. Heemskerk usually focuses on Cytotoxic T cell, concentrating on Immunotherapy and intersecting with Leukemia and Donor lymphocyte infusion.
In the field of Immunology, her study on Minor histocompatibility antigen, Spleen, Immune system and Homing overlaps with subjects such as Population.
The various areas that Mirjam H.M. Heemskerk examines in her T cell study include Computational biology and Antigen.
Mirjam H.M. Heemskerk combines subjects such as Molecular biology, Adoptive cell transfer, Human leukocyte antigen, Cell biology and CD3 with her study of T-cell receptor.
In her work, Natural killer cell is strongly intertwined with Stem cell, which is a subfield of CD8.
Her most cited work include:
- Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34+ cells in NOD/SCID mice (466 citations)
- Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. (393 citations)
- Inhibition of T Cell and Promotion of Natural Killer Cell Development by the Dominant Negative Helix Loop Helix Factor Id3 (261 citations)
What are the main themes of her work throughout her whole career to date?
Mirjam H.M. Heemskerk mainly focuses on Immunology, T cell, Cytotoxic T cell, Antigen and T-cell receptor.
Her work carried out in the field of Immunology brings together such families of science as Stem cell and Transplantation.
Her T cell study combines topics from a wide range of disciplines, such as Cancer research, Computational biology, Genetic enhancement and CD40.
She studied Antigen and Monoclonal antibody that intersect with B cell.
Her T-cell receptor research is multidisciplinary, relying on both Haematopoiesis, Molecular biology, Adoptive cell transfer, Cell biology and CD3.
Her Human leukocyte antigen research incorporates elements of MHC class I, CD8, Major histocompatibility complex, Antigen presentation and Peptide.
She most often published in these fields:
- Immunology (50.57%)
- T cell (38.07%)
- Cytotoxic T cell (36.36%)
What were the highlights of her more recent work (between 2015-2021)?
- Cancer research (23.30%)
- Immunology (50.57%)
- T cell (38.07%)
In recent papers she was focusing on the following fields of study:
Mirjam H.M. Heemskerk mostly deals with Cancer research, Immunology, T cell, Antigen and T-cell receptor.
Her Immunology research is multidisciplinary, incorporating perspectives in Cytotoxic T cell and Transplantation.
Her research investigates the connection between Cytotoxic T cell and topics such as Bone marrow that intersect with issues in Peripheral and Interferon gamma.
Her study in T cell is interdisciplinary in nature, drawing from both Human leukocyte antigen, CD8, CD40 and Cell biology.
Her work on Antigen is being expanded to include thematically relevant topics such as Immunotherapy.
Her biological study spans a wide range of topics, including Cell culture, Adoptive cell transfer, B cell and Cancer immunotherapy.
Between 2015 and 2021, her most popular works were:
- Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia. (58 citations)
- Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response (40 citations)
- PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma (38 citations)
In her most recent research, the most cited papers focused on:
- Immune system
- Gene
- Antibody
Mirjam H.M. Heemskerk spends much of her time researching Cancer research, Antigen, T-cell receptor, Immunotherapy and T cell.
Her Cancer research study incorporates themes from PRAME and Human leukocyte antigen.
The subject of her Antigen research is within the realm of Immunology.
Her Immunology research is multidisciplinary, incorporating elements of CD154 and Aspergillus.
Her T cell study integrates concerns from other disciplines, such as Virology, Epstein–Barr virus and Stem cell, Cell biology.
Her Minor histocompatibility antigen course of study focuses on Donor lymphocyte infusion and Cytotoxic T cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
